Bone marrow changes in heart transplant recipients with peripheral cytopenia

Transplantation

Volumn 67, Issue 6, 1999, Pages 840-846

  Castello, Alessandro ^a   Dal Bello, Barbara ^a   Klersy, Catherine ^a   Pistorio, Angela ^a   Viganò, Mario ^a   Ippoliti, Giambattista ^a   Arbustini, Eloisa ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b Istituto di Anatomia Patologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW BIOPSY; CANCER RISK; CYTOPENIA; ERYTHROPOIESIS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SCORING SYSTEM; STATISTICAL ANALYSIS;

EID: 0033608786     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903270-00010     Document Type: Article

References (32)

1. Goncalvesova E, Fabian J, Pacak J. Hematologic aspects of heart transplantation. Bratisl Lek Listy 1997; 98: 253.
2. Riccardi A, Giordano M, Girino M, et al. Refractory cytopenias: clinical course according to bone marrow cytology and cellularity. Blut 1987; 54: 153.
3. Lambertenghi-Deliliers G, Annaloro C, Soligo D, et al. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol 1992; 65: 61.
4. Castello A, Coci A, Magrini U, Ascari E. Histopathology of bone marrow metastases: considerations on 104 cases. Haematologica 1986; 71: 369.
5. Kilby JM, Marques MB, Jaye DL, Tabereaux PB, Reddy VB, Waites KB. The yield of bone marrow biopsy and culture compared with blood culture in the evaluation of HIV-infected patients for mycobacterial and fungal infections. Am J Med 1998; 104: 123.
6. Benito N, Nunez A, De Gorgolas M, et al. Bone marrow biopsy in the diagnosis of fever of unknown origin in patients with acquired immunodeficiency syndrome. Arch Intern Med 1997; 157: 1577.
7. Delacretaz P, Schmidt PM, Piguet D, Bachmann F, Costa J. Histopathology of myelodysplastic syndromes: the FAB classification (proposals) applied to bone marrow biopsy. Am J Clin Pathol 1987; 87: 180.
8. Hunt BJ, Amin S, Halil O, Yacoub M. The prevalence, course, and characteristics of chronic anemia after heart and lung transplantation. Transplantation 1992; 53: 1251.
9. Clatch RJ, Krigman HR, Peters MG, Zutter MM. Dysplastic haemopoiesis following orthotopic liver transplantation: comparison with similar changes in HPV infection and primary myelodysplasia. Br J Haematol 1994; 88: 685.
10. Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN. Wintrobe's clinical hematology. 9th edition. Malvern, PA; Lea & Febiger, 1993: 2298.
11. Arbustini E, Dal Bello B, Rinaldi M, et al. Acute rejection and heart infection rates in FK-506-versus cyclosporine A-treated heart transplant recipients: an endomyocardial biopsy pathologic study. J Heart Lung Transplant 1997; 16: 982.
12. Rinaldi M, Pellegrini C, Martinelli L, et al. FK506 effectiveness in reducing acute rejection after transplantation: a prospective randomized study. J Heart Lung Transplant 1997; 16: 1001.
13. Castello A, Coci A, Magrini U. Paraneoplastic alterations in patients with cancer. Haematologica 1992; 77: 392.
14. Coiffier B, Adeleine P, Viala JJ, et al. Dysmyelopoietic syndromes: a search for prognostic factors in 193 patients. Cancer 1983; 52: 83.
15. Tricot G, De Wolf-Peeters C, Vlietinck R, Verwilghen RL. Bone marrow histology in myelodysplastic syndromes. I. Histological findings in myelodysplastic syndromes and comparison with bone marrow smears. Br J Haematol 1984; 57: 423.
16. Morra E, Lazzarino M, Castello A, et al. Risk assessment in myelodysplastic syndromes: value of clinical, hematologic and bone marrow histologic findings at presentation. Eur J Haematol 1990; 45: 94.
17. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. J Heart Lung Transplant 1990; 9: 587.
18. Arbustini E, Grasso M, Diegoli M, et al. La biopsia endomiocardica nel paziente cardiotrapiantato: stato dell'arte. G Ital Cardiol 1991; 21: 1107.
19. Gao SZ, Alderman EL, Schroeder JS, Silverman JF, Hunt SA. Accelerated coronary vascular disease in the heart transplant patient: coronary arteriographic findings. J Am Coll Cardiol 1988; 12: 334.
20. Arbustini E, Dal Bello B, Morbini P, et al. Frequency and characteristics of coronary thrombosis in the epicardial coronary arteries after cardiac transplantation. Am J Cardiol 1996; 78: 795.
21. Grossi P, Minoli L, Percivalle E, Irish W, Viganò M, Gerna G. Clinical and virological monitoring of human cytomegalovirus infection in 294 heart transplant recipients. Transplantation 1995; 59: 847.
22. Grossi P, Dalla Gasperina D, Comolli G, et al. Prevalence and outcome of hepatitis C virus infection in a series of 509 thoracic organ transplant recipients. J Heart Lung Transplant 1997; 16: 109.
23. Connell WR, Kamm MA, Ritchie JK, Lennard-Jones JE. Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience. Gut 1993; 34: 1081.
24. Cummins D, Sekar M, Halil O, Banner N. Myelosuppression associated with azathioprine-allopurinol interaction after heart and lung transplantation. Transplantation 1996; 61: 1661.
25. Scott JP, Hingenbottam JW. Adverse reactions and interactions of cyclosporin. Med Toxicol Adverse Drug Exp 1988; 3: 107.
26. Bacialugo A, van Lint MT, Tedone E, et al. Early treatment of CMV infections in allogenic bone marrow transplant recipients with foscarnet or ganciclovir. Bone Marrow Transplant 1994; 13: 753.
27. Momin F, Chandrasekar PH. Antimicrobial prophylaxis in bone marrow transplantation. Ann Intern Med 1995; 123: 205.
28. Zoumbos NC, Djeu JY, Young NS. Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 1984; 133: 769.
29. Arbustini E, Dal Bello B, Morbini P, et al. Factors increasing the risk of allograft vascular disease in heart transplant recipients. G Ital Cardiol 1997; 27: 985.
30. Opelz G, Wujciak T. The influence of HLA compatibility on graft survival after heart transplantation. The Collaborative Transplant Study. N Engl J Med 1994; 330: 816.
31. Kirsch M, Baufreton C, Naftel DC, Benvenuti C, Loisance DY. Pretransplantation risk factors for death after heart transplantation: the Henri Mondor experience. J Heart Lung Transplant 1998; 17: 268.
32. Koelling TM, Semigran MJ, Mijller-Ehmsen J, et al. Left ventricular end-diastolic volume index, age, and maximum heart rate at peak exercise predict survival in patients referred for heart transplantation. J Heart Lung Transplant 1998; 17: 278.